The JDP2 shRNAs did not demonstrate broad toxicity across a panel of cancer cell lines as determined through the Achilles project (Fig. S2 A; Tsherniak et al., 2017), nor in DND-41 T-ALL cells that do not express JDP2 (Fig. S2 B). The gene discussed is JDP2; the disease is cancer.